Different modes of weight loss in Alzheimer disease: a prospective study of 395 patients.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 16087990)

Published in Am J Clin Nutr on August 01, 2005

Authors

Olivier Guérin1, Sandrine Andrieu, Stéphane M Schneider, Morgan Milano, Rabia Boulahssass, Patrice Brocker, Bruno Vellas

Author Affiliations

1: Department of Gerontology, University Hospital, Nice, France.

Articles citing this

Adiposity and Alzheimer's disease. Curr Opin Clin Nutr Metab Care (2009) 1.17

Reframing person-centered nursing care for persons with dementia. Res Theory Nurs Pract (2007) 1.03

Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord (2014) 0.99

Prevention of dementia: focus on lifestyle. Int J Alzheimers Dis (2010) 0.85

A practical algorithm for managing Alzheimer's disease: what, when, and why? Ann Clin Transl Neurol (2015) 0.84

Relationship between cognitive impairment and nutritional assessment on functional status in Calabrian long-term-care. Clin Interv Aging (2014) 0.84

Nutrition in severe dementia. Curr Gerontol Geriatr Res (2012) 0.80

Enteral nutrition in dementia: a systematic review. Nutrients (2015) 0.78

Change in body mass index before and after Alzheimer's disease onset. Curr Alzheimer Res (2014) 0.78

Weight loss and undernutrition in community-dwelling patients with Alzheimer's dementia: From population based studies to clinical management. Z Gerontol Geriatr (2015) 0.77

Weight Loss Predicts Progression of Mild Cognitive Impairment to Alzheimer's Disease. PLoS One (2016) 0.77

Nutritional status among older residents with dementia in open versus special care units in municipal nursing homes: an observational study. BMC Geriatr (2013) 0.77

Metabolic changes over the course of aging in a mouse model of tau deposition. Neurobiol Aging (2016) 0.75

The relationship of weight change trajectory with medial temporal lobe atrophy in patients with mild Alzheimer's disease: results from a cohort study. Alzheimers Res Ther (2015) 0.75

Cognitive function, body weight and body composition in geriatric patients. Z Gerontol Geriatr (2007) 0.75

Articles by these authors

Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing (2010) 17.45

Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. N Engl J Med (2014) 6.67

Frailty consensus: a call to action. J Am Med Dir Assoc (2013) 6.54

A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement (2008) 6.39

Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc (2011) 5.96

Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol (2015) 5.10

Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimers Dement (2010) 4.85

A phase 3 trial of semagacestat for treatment of Alzheimer's disease. N Engl J Med (2013) 4.11

Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial. J Am Geriatr Soc (2007) 4.05

Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry (2010) 3.64

Frequency of malnutrition in older adults: a multinational perspective using the mini nutritional assessment. J Am Geriatr Soc (2010) 3.05

Outcome of Alzheimer's disease: potential impact of cholinesterase inhibitors. J Gerontol A Biol Sci Med Sci (2006) 2.76

Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol (2012) 2.65

Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc (2011) 2.34

Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging (2010) 2.27

Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force. Alzheimers Dement (2013) 1.98

Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study. J Am Geriatr Soc (2003) 1.93

The assessment of frailty in older adults. Clin Geriatr Med (2010) 1.89

Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden. J Am Geriatr Soc (2003) 1.83

Diabetes is associated with subclinical functional limitation in nondisabled older individuals: the Health, Aging, and Body Composition study. Diabetes Care (2003) 1.77

Physical performance measures as predictors of mortality in a cohort of community-dwelling older French women. Eur J Epidemiol (2006) 1.76

Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease. Int Psychogeriatr (2002) 1.73

Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc (2013) 1.69

Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) Study. Am J Clin Nutr (2009) 1.68

Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease. Neurobiol Aging (2011) 1.57

Endpoints for trials in Alzheimer's disease: a European task force consensus. Lancet Neurol (2008) 1.51

Aggressive course of disease in dementia. Alzheimers Dement (2006) 1.44

Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls. Neuroimage (2010) 1.44

Patient and caregiver perspectives of quality of life in dementia. An investigation of the relationship to behavioural and psychological symptoms in dementia. Dement Geriatr Cogn Disord (2008) 1.41

Sensory alien hand syndrome in corticobasal degeneration: a cerebral blood flow study. Mov Disord (2010) 1.40

Minimum data set for nutritional intervention studies in elderly people. J Gerontol A Biol Sci Med Sci (2004) 1.40

Early prediction of failure to lose weight after obesity surgery. Surg Obes Relat Dis (2011) 1.40

Normalized Mini-Mental State Examination for assessing cognitive change in population-based brain aging studies. Neuroepidemiology (2014) 1.39

Music perception in adult cochlear implant recipients. Acta Otolaryngol (2003) 1.38

Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I. Dement Geriatr Cogn Disord (2007) 1.38

Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia. J Cachexia Sarcopenia Muscle (2012) 1.37

Frailty: toward a clinical definition. J Am Med Dir Assoc (2008) 1.36

The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months. Int J Geriatr Psychiatry (2011) 1.35

Dementia prevention: methodological explanations for inconsistent results. Epidemiol Rev (2008) 1.35

The frailty phenotype and the frailty index: different instruments for different purposes. Age Ageing (2013) 1.35

Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment. Neuroimage (2011) 1.34

AddNeuroMed--the European collaboration for the discovery of novel biomarkers for Alzheimer's disease. Ann N Y Acad Sci (2009) 1.30

Disease-modifying trials in Alzheimer's disease: a European task force consensus. Lancet Neurol (2007) 1.29

'Clinical trials in Alzheimer's disease': immunotherapy approaches. J Neurochem (2011) 1.29

Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study. J Alzheimers Dis (2014) 1.29

MRI measures of Alzheimer's disease and the AddNeuroMed study. Ann N Y Acad Sci (2009) 1.28

Muscle strength in obese elderly women: effect of recreational physical activity in a cross-sectional study. Am J Clin Nutr (2004) 1.26

Biomarkers for Alzheimer's disease therapeutic trials. Prog Neurobiol (2010) 1.26

Diabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition study. Diabetes Care (2006) 1.26

Nutritional deficiencies in patients with Crohn's disease in remission. Inflamm Bowel Dis (2006) 1.26

Physical activity and Alzheimer's disease: from prevention to therapeutic perspectives. J Am Med Dir Assoc (2008) 1.24

Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res (2006) 1.24

AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage (2011) 1.24

International Association of Gerontology and Geriatrics: a global agenda for clinical research and quality of care in nursing homes. J Am Med Dir Assoc (2011) 1.22

Is there a relationship between fat-free soft tissue mass and low cognitive function? Results from a study of 7,105 women. J Am Geriatr Soc (2002) 1.20

Nutrition and neurodegeneration: epidemiological evidence and challenges for future research. Br J Clin Pharmacol (2013) 1.15

Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study. J Alzheimers Dis (2010) 1.12

Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease. Neurobiol Aging (2013) 1.12

Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease. Nat Rev Drug Discov (2013) 1.12

Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J Alzheimers Dis (2012) 1.11

Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood. J Alzheimers Dis (2012) 1.11

Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II. Dement Geriatr Cogn Disord (2007) 1.10

Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease. PLoS One (2011) 1.10

Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. Eur Psychiatry (2005) 1.09

Caloric restriction and brain function. Curr Opin Clin Nutr Metab Care (2008) 1.09

Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI). Exp Gerontol (2009) 1.09

Clinical relevance of different muscle strength indexes and functional impairment in women aged 75 years and older. J Gerontol A Biol Sci Med Sci (2012) 1.09

Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups--the AddNeuroMed study. Neurobiol Aging (2009) 1.09

Gait speed, body composition, and dementia. The EPIDOS-Toulouse cohort. J Gerontol A Biol Sci Med Sci (2011) 1.09

Population ageing and health. Lancet (2012) 1.08

Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer's disease trials. Alzheimers Dement (2011) 1.08

Effectiveness of a specific care plan in patients with Alzheimer's disease: cluster randomised trial (PLASA study). BMJ (2010) 1.08

Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease. Neurobiol Aging (2010) 1.08

Informal caregiving and self-reported mental and physical health: results from the Gazel Cohort Study. Am J Public Health (2011) 1.08

Cachexia versus sarcopenia. Curr Opin Clin Nutr Metab Care (2011) 1.07

Plasma biomarkers of brain atrophy in Alzheimer's disease. PLoS One (2011) 1.06

Beyond the global score of the Zarit Burden Interview: useful dimensions for clinicians. Int J Geriatr Psychiatry (2005) 1.05

A blood gene expression marker of early Alzheimer's disease. J Alzheimers Dis (2013) 1.05

The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium. Alzheimers Dement (2008) 1.05

Alzhemed: a potential treatment for Alzheimer's disease. Curr Alzheimer Res (2007) 1.05

Different multivariate techniques for automated classification of MRI data in Alzheimer's disease and mild cognitive impairment. Psychiatry Res (2013) 1.05

Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI). J Neurol Sci (2012) 1.04

Methodological issues in primary prevention trials for neurodegenerative dementia. J Alzheimers Dis (2009) 1.04

Higher vitamin D dietary intake is associated with lower risk of alzheimer's disease: a 7-year follow-up. J Gerontol A Biol Sci Med Sci (2012) 1.04

Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR Study. Alzheimers Dement (2008) 1.03

Creating a transatlantic research enterprise for preventing Alzheimer's disease. Alzheimers Dement (2009) 1.02

Prevention trials in Alzheimer's disease: an EU-US task force report. Prog Neurobiol (2011) 1.02